139 related articles for article (PubMed ID: 29016849)
1. Differential protective effects of connective tissue growth factor against Aβ neurotoxicity on neurons and glia.
Yang CN; Wu MF; Liu CC; Jung WH; Chang YC; Lee WP; Shiao YJ; Wu CL; Liou HH; Lin SK; Chan CC
Hum Mol Genet; 2017 Oct; 26(20):3909-3921. PubMed ID: 29016849
[TBL] [Abstract][Full Text] [Related]
2. Glial Draper Rescues Aβ Toxicity in a
Ray A; Speese SD; Logan MA
J Neurosci; 2017 Dec; 37(49):11881-11893. PubMed ID: 29109235
[TBL] [Abstract][Full Text] [Related]
3. Ultrasound-mediated augmented exosome release from astrocytes alleviates amyloid-β-induced neurotoxicity.
Deng Z; Wang J; Xiao Y; Li F; Niu L; Liu X; Meng L; Zheng H
Theranostics; 2021; 11(9):4351-4362. PubMed ID: 33754065
[No Abstract] [Full Text] [Related]
4. Astrocytic LRP1 Mediates Brain Aβ Clearance and Impacts Amyloid Deposition.
Liu CC; Hu J; Zhao N; Wang J; Wang N; Cirrito JR; Kanekiyo T; Holtzman DM; Bu G
J Neurosci; 2017 Apr; 37(15):4023-4031. PubMed ID: 28275161
[TBL] [Abstract][Full Text] [Related]
5. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
Wu X; Kosaraju J; Zhou W; Tam KY
ACS Chem Neurosci; 2017 Mar; 8(3):676-685. PubMed ID: 28032988
[TBL] [Abstract][Full Text] [Related]
7. Astrocytes from old Alzheimer's disease mice are impaired in Aβ uptake and in neuroprotection.
Iram T; Trudler D; Kain D; Kanner S; Galron R; Vassar R; Barzilai A; Blinder P; Fishelson Z; Frenkel D
Neurobiol Dis; 2016 Dec; 96():84-94. PubMed ID: 27544484
[TBL] [Abstract][Full Text] [Related]
8. SH2B1 is Involved in the Accumulation of Amyloid-β42 in Alzheimer's Disease.
Shen Y; Xia Y; Meng S; Lim NK; Wang W; Huang F
J Alzheimers Dis; 2017; 55(2):835-847. PubMed ID: 27802221
[TBL] [Abstract][Full Text] [Related]
9. A peptide that binds specifically to the β-amyloid of Alzheimer's disease: selection and assessment of anti-β-amyloid neurotoxic effects.
Wang F; Zhou XL; Yang QG; Xu WH; Wang F; Chen YP; Chen GH
PLoS One; 2011; 6(11):e27649. PubMed ID: 22102917
[TBL] [Abstract][Full Text] [Related]
10. The flavonoid derivative 2-(4' Benzyloxyphenyl)-3-hydroxy-chromen-4-one protects against Aβ42-induced neurodegeneration in transgenic Drosophila: insights from in silico and in vivo studies.
Singh SK; Gaur R; Kumar A; Fatima R; Mishra L; Srikrishna S
Neurotox Res; 2014 Nov; 26(4):331-50. PubMed ID: 24706035
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective Effects of Ginsenoside Rf on Amyloid-β-Induced Neurotoxicity in vitro and in vivo.
Du Y; Fu M; Wang YT; Dong Z
J Alzheimers Dis; 2018; 64(1):309-322. PubMed ID: 29865080
[TBL] [Abstract][Full Text] [Related]
12. Harpagoside ameliorates the amyloid-β-induced cognitive impairment in rats via up-regulating BDNF expression and MAPK/PI3K pathways.
Li J; Ding X; Zhang R; Jiang W; Sun X; Xia Z; Wang X; Wu E; Zhang Y; Hu Y
Neuroscience; 2015 Sep; 303():103-14. PubMed ID: 26135675
[TBL] [Abstract][Full Text] [Related]
13. Oleuropein aglycone counteracts Aβ42 toxicity in the rat brain.
Luccarini I; Ed Dami T; Grossi C; Rigacci S; Stefani M; Casamenti F
Neurosci Lett; 2014 Jan; 558():67-72. PubMed ID: 24211687
[TBL] [Abstract][Full Text] [Related]
14. pGluAβ increases accumulation of Aβ in vivo and exacerbates its toxicity.
Sofola-Adesakin O; Khericha M; Snoeren I; Tsuda L; Partridge L
Acta Neuropathol Commun; 2016 Oct; 4(1):109. PubMed ID: 27717375
[TBL] [Abstract][Full Text] [Related]
15. Targeting group II metabotropic glutamate (mGlu) receptors for the treatment of psychosis associated with Alzheimer's disease: selective activation of mGlu2 receptors amplifies beta-amyloid toxicity in cultured neurons, whereas dual activation of mGlu2 and mGlu3 receptors is neuroprotective.
Caraci F; Molinaro G; Battaglia G; Giuffrida ML; Riozzi B; Traficante A; Bruno V; Cannella M; Merlo S; Wang X; Heinz BA; Nisenbaum ES; Britton TC; Drago F; Sortino MA; Copani A; Nicoletti F
Mol Pharmacol; 2011 Mar; 79(3):618-26. PubMed ID: 21159998
[TBL] [Abstract][Full Text] [Related]
16. Exosomal cellular prion protein drives fibrillization of amyloid beta and counteracts amyloid beta-mediated neurotoxicity.
Falker C; Hartmann A; Guett I; Dohler F; Altmeppen H; Betzel C; Schubert R; Thurm D; Wegwitz F; Joshi P; Verderio C; Krasemann S; Glatzel M
J Neurochem; 2016 Apr; 137(1):88-100. PubMed ID: 26710111
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.
Shackleton B; Crawford F; Bachmeier C
Fluids Barriers CNS; 2016 Aug; 13(1):14. PubMed ID: 27503326
[TBL] [Abstract][Full Text] [Related]
18. A probe for NIR-II imaging and multimodal analysis of early Alzheimer's disease by targeting CTGF.
Lu C; Meng C; Li Y; Yuan J; Ren X; Gao L; Su D; Cao K; Cui M; Yuan Q; Gao X
Nat Commun; 2024 Jun; 15(1):5000. PubMed ID: 38866763
[TBL] [Abstract][Full Text] [Related]
19. Brain aging and Aβ₁₋₄₂ neurotoxicity converge via deterioration in autophagy-lysosomal system: a conditional Drosophila model linking Alzheimer's neurodegeneration with aging.
Ling D; Salvaterra PM
Acta Neuropathol; 2011 Feb; 121(2):183-91. PubMed ID: 21076961
[TBL] [Abstract][Full Text] [Related]
20. GM1-Modified Lipoprotein-like Nanoparticle: Multifunctional Nanoplatform for the Combination Therapy of Alzheimer's Disease.
Huang M; Hu M; Song Q; Song H; Huang J; Gu X; Wang X; Chen J; Kang T; Feng X; Jiang D; Zheng G; Chen H; Gao X
ACS Nano; 2015 Nov; 9(11):10801-16. PubMed ID: 26440073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
